NCT06272617

Brief Summary

A study on the efficacy and safety of acupuncture for the prevention and treatment of oral-related complications caused by radiotherapy for head and neck malignant tumors

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
138

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 25, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

January 30, 2024

Completed
23 days until next milestone

First Posted

Study publicly available on registry

February 22, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 24, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 24, 2025

Completed
Last Updated

February 22, 2024

Status Verified

February 1, 2024

Enrollment Period

1 year

First QC Date

January 30, 2024

Last Update Submit

February 21, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Xerostomia questionnaire scores

    Patients self-evaluated xerostomia according to Xerostomia questionnaire(score 0-100);Higher score indicates more severe symptoms

    1 week before radiotherapy;weekly during the treatment(every 5 radiotherapy sessions);1, 3, 6, 12 months after the end of treatment

Secondary Outcomes (12)

  • Salivary flow rate

    1 week before radiotherapy;weekly during the treatment(every 5 radiotherapy sessions);1, 3, 6, 12 months after the end of treatment

  • Taste function assessed by patients

    1 week before radiotherapy;weekly during the treatment(every 5 radiotherapy sessions);1, 3, 6, 12 months after the end of treatment

  • Taste function assessed by electrogustometer test

    1 week before radiotherapy;weekly during the treatment(every 5 radiotherapy sessions);1, 3, 6, 12 months after the end of treatment

  • Taste function assessed by taste strips test

    1 week before radiotherapy;weekly during the treatment(every 5 radiotherapy sessions);1, 3, 6, 12 months after the end of treatment

  • Oral mucositis

    1 week before radiotherapy;twice a week during the treatment(usually every 3 radiotherapy sessions);1, 3, 6, 12 months after the end of treatment

  • +7 more secondary outcomes

Study Arms (2)

treatment group

EXPERIMENTAL

verum acupuncture

Device: verum acupuncture

control group

SHAM COMPARATOR

sham acupuncture

Device: sham acupuncture

Interventions

a type of acupuncture which is useful

treatment group

a type of acupuncture which is useless

control group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed with malignant tumors of the head and neck without metastasis
  • Age ≥18, ≤80 years old
  • ZPS score ≤2
  • Receiving radiotherapy alone or concurrent radiotherapy with a radiation dose of \>50 Gy, including at least one parotid gland
  • Judged to be able to receive acupuncture treatment, with all needle positions identified as accessible
  • Signed informed consent form

You may not qualify if:

  • History of dry mouth, Sjogren's syndrome, or other underlying systemic condition known to cause dry mouth
  • Suspected or confirmed physical closure of both salivary gland ducts
  • Have a phobia of needles or prohibit the use of acupuncture at any acupuncture points
  • Have a history of head and neck radiotherapy
  • Have contraindications to acupuncture, including but not limited to bleeding disorders, having skin infections, ulcers or frequent infections
  • Have taken any medications or herbs within the past 30 days that may affect salivary function, plan to or eventually take such substances during the study period
  • Poor oral hygiene or severe periodontitis
  • Poor compliance
  • Other patients who, in the opinion of the investigator, are not suitable for participation in this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

West China Hospital, Sichuan University

Chengdu, Sichuan, China

RECRUITING

MeSH Terms

Conditions

Head and Neck Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasms

Study Officials

  • Xingchen Peng

    West China Hospital

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 30, 2024

First Posted

February 22, 2024

Study Start

July 25, 2023

Primary Completion

July 24, 2024

Study Completion

July 24, 2025

Last Updated

February 22, 2024

Record last verified: 2024-02

Locations